Amanda Watts v. Medicis Pharmaceutical Corporation

Vice Chief Justice PELANDER,

opinion of the Court.

¶ 1 Under the learned intermediary doctrine (“LID”), a manufacturer satisfies its duty to warn end users by giving appropriate warnings to the specialized class of persons who may prescribe or administer the product. We hold today that the LID generally applies to a prescription drug manufacturer. We further conclude that the LID is not displaced by the Uniform Contribution Among Tortfeasors Act (“UCATA”), A.R.S. §§ 12-2501 through -2509. Finally, we hold that prescription drugs are “merchandise” for purposes of the Consumer Fraud Act (“CFA”),…